Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA (VISTN) · publisert 30. mai 2023 kl. 21:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Øystein Stray Spetalen via Ferncliff Listed DAI AS | Styremedlem | Kjøp | 250 000 | 23,12 NOK | 30. mai 2023 | NO0010734122 | Oslo Stock Exchange, MIC: XOSL |
Vedlegg
- 20230530_Notification of trade_Ferncliff i Vistin.pdf (application/pdf, originaldokument)
Meldingstekst
Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin
Pharma ASA at NOK 23.12 per share.
After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares,
corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated
with board member Øystein Stray Spetalen.